| David F Stuebe, PT | |
|
125 Hospital Dr, Watertown, WI 53098-3303 | |
| (920) 262-4220 | |
| Not Available |
| Full Name | David F Stuebe |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 125 Hospital Dr, Watertown, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447471115 | NPI | - | NPPES |
| 36115000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 6122024 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David F Stuebe, PT 309 Lincoln Ave, Reeseville, WI 53579-9500 Ph: (920) 927-2228 | David F Stuebe, PT 125 Hospital Dr, Watertown, WI 53098-3303 Ph: (920) 262-4220 |
News Archive
Low-dose CT lung cancer screening is associated with a 16 percent relative reduction in lung cancer mortality, when compared against a non-LDCT control arm, according to research presented by Professor John Field and the United Kingdom Cancer Screening Trial (UKLS) Team today at the IASLC 2021 World Conference on Lung Cancer. The research will be published in the Lancet Regional Health-Europe.
In pursuit of a novel tool for the research and treatment of celiac disease, scientists at the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital have validated the use of intestinal organoids.
Despite decades of scientific scrutiny, Alzheimer's disease researchers have yet to work out its cause or treatment. Understanding what underlies its three distinct subtypes is thought to be a promising new research avenue.
The World Health Organization is calling on belligerents in Syria to allow for the immediate and safe evacuation of the sick and wounded from all areas affected by the conflict, including eastern Aleppo.
Santaris Pharma announced today that SPC3042, a RNA-based antisense oligonucleotide developed using the company's proprietary Locked Nucleic Acid (LNA) technology, potently blocks survivin, a key survival protein in cancer cells, in both in vitro and in vivo models of prostate cancer. Importantly, SPC3042 works synergistically with the anticancer drug paclitaxel (Taxol) in both model systems.
› Verified 5 days ago
Thuan Van Ngo, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1020 Hill St, Watertown, WI 53098 Phone: 920-261-0400 | |
Christian Long, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: Watertown Regional Medical Center, 1684 S Church St, Watertown, WI 53094 Phone: 920-262-4220 | |
Ms. Julie Patrice Amundson, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 125 Hospital Dr, Watertown, WI 53098 Phone: 920-262-4220 Fax: 920-262-4393 | |
Taylor Johnson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1508 S Church St, Watertown, WI 53094 Phone: 920-245-3773 | |
Mrs. Sherry Ann Strupp, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 125 Hospital Dr, Watertown, WI 53098 Phone: 920-262-4220 | |
Benjamin Wesolowski, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1508 S Church St, Watertown, WI 53094 Phone: 800-974-4378 Fax: 630-515-1536 | |
Mrs. Laurie E Mitchell, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 125 Hospital Dr, Watertown, WI 53098 Phone: 920-262-4220 |